VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sable Resources Ltd. ('Sable” or the 'Company”) (TSXV: SAE | OTCQB: SBLRF) announces today that, further to its press release of July 29, 2026 it has completed the proposed consolidation of the Company’s issued and outstanding common shares ('Shares”) on the basis of one post-consolidation Share for every ten pre-consolidation Shares (the 'Consolidation”). The Shares will begin trading on a post-Consolidation basis on the TSX Venture

Exicom Tele-Systems Limited reported a dilution in its stake in subsidiary Exicom Power Solutions B.V. from 92.23% to 90.29%. This follows the conversion of USD 1.5 million in Optionally Convertible Debentures (OCDs) into equity shares. Cumulative conversions have now reached USD 7 million out of an initial USD 10 million issuance to a foreign investor.

Wayfair, a pandemic darling that's seen sales slow since lockdown orders were lifted, posted its strongest U.S. growth since 2020 during its second quarter.

Marico's EBITDA increased 25% to ₹819 crore from ₹655 crore a year earlier, compared with the CNBC-TV18 poll estimate of ₹776 crore. EBITDA margin expanded to 20.7% from 20.1% in the year-ago quarter, higher than the poll estimate of 19.8%.

India has laid the legal groundwork to reintroduce merchant fees on UPI payments through proposed amendments to the Payment and Settlement Systems Act. While no decision has been taken, the government is considering charging MDR only on large merchants or high-value transactions, potentially creating a ₹5,000-10,000 crore revenue pool for payment firms.

/PRNewswire/ -- Energizer Holdings, Inc. (NYSE: ENR) today announced results for the third fiscal quarter ended June 30, 2026....

/PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, today reported financial results for the second quarter ended...

Morepen Laboratories a publicat rezultatele pentru trimestrul încheiat la 30 iunie 2026, raportând venituri record de 575.31 Cr Rs (+34% față de anul anterior) și un profit net (PAT) de 56.35 Cr Rs (+394%). EBITDA a urcat la 87.72 Cr Rs (+207%), iar marja EBITDA s-a îmbunătățit de la 6.65% la 15.25%. Compania a anunțat că un mandat CDMO de 825 Cr Rs a intrat în faza de comercializare la scară completă, iar în trimestru a realizat deja livrări comerciale de 58 Cr Rs. Potrivit companiei, rezultatele reflectă progrese semnificative în CDMO și în exporturile de ingrediente farmaceutice active (API).